Yearly Archives: 2017

Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science

October 2017

Manchester, 4 October 2017 – Phagenesis announced today that by completing a key clinical study in Europe it has reached the first milestone in its staged acquisition agreement with Nestlé Health Science (NHSc). Under the terms of the agreement, Nestlé … Continue reading

Posted in General updates, news | Comments Off on Phagenesis has successfully reached the first of two milestones in its staged acquisition agreement with Nestlé Health Science

Phagenyx® Next Generation Catheter is launched at 7th ESSD Congress and World Dysphagia Summit, 18-23 September 2017

September 2017

Barcelona, Spain – 21st September 2017 – Phagenesis announced today the official launch of the Phagenyx® Next Generation catheter, the result of company’s engagement to continuous innovation and product improvement. The participants at 7th ESSD Congress and World Dysphagia Summit, … Continue reading

Posted in General updates | Comments Off on Phagenyx® Next Generation Catheter is launched at 7th ESSD Congress and World Dysphagia Summit, 18-23 September 2017

Phagenyx® Next Generation Catheter obtains CE Mark

July 2017

Manchester, UK – 21st July 2017 – Phagenesis Ltd, an important leader in the treatment of dysphagia, announced today that Phagenyx® Next Generation catheter got CE Mark for neurogenic dysphagia. Dysphagia (the inability to swallow safely) is a condition with … Continue reading

Posted in General updates | Comments Off on Phagenyx® Next Generation Catheter obtains CE Mark